News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
318,254 Results
Type
Article (16535)
Company Profile (308)
Press Release (301402)
Multimedia
Podcasts (83)
Webinars (14)
Section
Business (90871)
Career Advice (491)
Deals (15119)
Drug Delivery (48)
Drug Development (52686)
Employer Resources (75)
FDA (6448)
Job Trends (6349)
News (161848)
Policy (12196)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1170)
Academic (1)
Accelerated approval (21)
Adcomms (14)
Allergies (87)
Alliances (25011)
ALS (136)
Alzheimer's disease (1123)
Antibody-drug conjugate (ADC) (247)
Approvals (6636)
Artificial intelligence (307)
Autoimmune disease (122)
Automation (12)
Bankruptcy (127)
Best Places to Work (5599)
BIOSECURE Act (8)
Biosimilars (105)
Biotechnology (233)
Bladder cancer (101)
Brain cancer (48)
Breast cancer (361)
Cancer (3324)
Cardiovascular disease (249)
Career advice (439)
Career pathing (14)
CAR-T (229)
CDC (8)
Cell therapy (582)
Cervical cancer (16)
Clinical research (45404)
Collaboration (1239)
Company closure (2)
Compensation (600)
Complete response letters (39)
COVID-19 (1204)
CRISPR (87)
C-suite (599)
Cystic fibrosis (116)
Data (4538)
Decentralized trials (1)
Denatured (20)
Depression (96)
Diabetes (282)
Diagnostics (1764)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (20)
Drug discovery (204)
Drug pricing (60)
Drug shortages (5)
Duchenne muscular dystrophy (217)
Earnings (35240)
Editorial (26)
Employer branding (7)
Employer resources (67)
Events (57176)
Executive appointments (671)
FDA (8358)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1040)
Gene editing (184)
Generative AI (24)
Gene therapy (502)
GLP-1 (552)
Government (1526)
Grass and pollen (3)
Guidances (201)
Healthcare (8393)
HIV (25)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (196)
Immuno-oncology (45)
Indications (68)
Infectious disease (1320)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (46)
Intellectual property (177)
Interviews (75)
IPO (8097)
IRA (17)
Job creations (1016)
Job search strategy (373)
JPM (48)
Kidney cancer (9)
Labor market (30)
Layoffs (270)
Leadership (20)
Legal (2145)
Liver cancer (44)
Longevity (11)
Lung cancer (442)
Lymphoma (276)
Machine learning (29)
Management (25)
Manufacturing (422)
MASH (137)
Medical device (3608)
Medtech (3624)
Mergers & acquisitions (7693)
Metabolic disorders (779)
Multiple sclerosis (110)
NASH (13)
Neurodegenerative disease (247)
Neuropsychiatric disorders (71)
Neuroscience (2097)
Neurotech (1)
NextGen: Class of 2026 (2812)
Non-profit (1690)
Now hiring (34)
Obesity (349)
Opinion (162)
Ovarian cancer (136)
Pain (110)
Pancreatic cancer (164)
Parkinson's disease (246)
Partnered (20)
Patents (320)
Patient recruitment (347)
Peanut (45)
People (30215)
Pharmaceutical (46)
Pharmacy benefit managers (8)
Phase 1 (15971)
Phase 2 (21007)
Phase 3 (13410)
Pipeline (3543)
Policy (117)
Postmarket research (968)
Preclinical (6697)
Press Release (34)
Prostate cancer (157)
Psychedelics (51)
Radiopharmaceuticals (240)
Rare diseases (681)
Real estate (1761)
Recruiting (30)
Regulatory (11090)
Reports (24)
Research institute (1184)
Resumes & cover letters (47)
Rett syndrome (24)
RNA editing (21)
RSV (20)
Schizophrenia (127)
Series A (188)
Series B (140)
Service/supplier (1)
Sickle cell disease (80)
Special edition (19)
Spinal muscular atrophy (121)
Sponsored (23)
Startups (2138)
State (1)
Stomach cancer (5)
Supply chain (42)
Tariffs (22)
The Weekly (62)
Vaccines (370)
Venture capital (73)
Weight loss (189)
Women's health (32)
Worklife (10)
Date
Today (60)
Last 7 days (350)
Last 30 days (1277)
Last 365 days (19323)
2026 (1865)
2025 (19565)
2024 (22168)
2023 (24259)
2022 (29170)
2021 (30743)
2020 (27001)
2019 (20850)
2018 (15143)
2017 (15327)
2016 (13510)
2015 (16165)
2014 (11641)
2013 (8427)
2012 (8642)
2011 (8853)
2010 (8362)
Location
Africa (234)
Alabama (70)
Alaska (2)
Arizona (91)
Arkansas (6)
Asia (20721)
Australia (3401)
California (7421)
Canada (2061)
China (832)
Colorado (263)
Connecticut (310)
Delaware (243)
Europe (42547)
Florida (997)
Georgia (229)
Hawaii (2)
Idaho (30)
Illinois (452)
India (40)
Indiana (193)
Iowa (9)
Japan (242)
Kansas (84)
Kentucky (11)
Louisiana (7)
Maine (14)
Maryland (847)
Massachusetts (5800)
Michigan (121)
Minnesota (300)
Mississippi (3)
Missouri (46)
Montana (24)
Nebraska (6)
Nevada (43)
New Hampshire (23)
New Jersey (1836)
New Mexico (15)
New York (1933)
North Carolina (908)
North Dakota (6)
Northern California (3638)
Ohio (191)
Oklahoma (12)
Oregon (24)
Pennsylvania (1353)
Puerto Rico (10)
Rhode Island (28)
South America (306)
South Carolina (17)
Southern California (2916)
Tennessee (65)
Texas (989)
United States (25117)
Utah (113)
Virginia (155)
Washington D.C. (43)
Washington State (631)
West Virginia (2)
Wisconsin (51)
318,254 Results for "engage therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
The back-heavy deal includes a $5 million upfront payment for two novel T cell engagers, though the companies have yet to disclose priority indications.
November 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases
January 8, 2026
·
3 min read
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Press Releases
Patient Advocacy, Health Equity, and Community Engagement in Clinical Research: An Interview with Ekta Grewal
January 19, 2026
·
1 min read
Press Releases
Abalos Therapeutics to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with Bispecific T-cell Engagers at SITC 2025
November 5, 2025
·
3 min read
Press Releases
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
February 2, 2026
·
7 min read
Press Releases
Trethera Successfully Completes Phase 1 Dose Escalation Trial Demonstrating Broad Therapeutic Window, Favorable Safety, and Confirmed Target Engagement
October 29, 2025
·
7 min read
Job Trends
Employee Engagement, Workforce Sentiment Down in 2024
Global employee engagement fell two percentage points in 2024, according to Gallup, while
BioSpace
found that workforce sentiment decreased among biopharma professionals. Additionally, a recent
BioSpace
poll suggests engagement could continue to decline in 2025.
May 1, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA™ Circular RNA Therapeutics
August 27, 2025
·
4 min read
Press Releases
Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
December 2, 2025
·
8 min read
1 of 31,826
Next
